RiverPark Advisors’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,304,598
Closed -$13M 240
2021
Q3
$13M Hold
1,304,598
1.58% 24
2021
Q2
$12.9M Buy
+1,304,598
New +$12.9M 1.65% 25